How to deal with oxygen radicals stemming from mitochondrial fatty acid oxidation

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 369, Issue 1646, 2014, Pages

  Speijer, D ^a   Manjeri, G R ^b   Szklarczyk, R ^b,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complex I; Neurodegenerative disorder; Peroxisome; Radical formation; Supercomplex

Indexed keywords

EUKARYOTE; FATTY ACID; GLUCOSE; MITOCHONDRION; OXIDATION; OXYGEN;

FATTY ACID; REACTIVE OXYGEN METABOLITE;

DEGENERATIVE DISEASE; ELECTRON TRANSPORT; HUMAN; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; PEROXISOME; PHYSIOLOGY;

ELECTRON TRANSPORT; FATTY ACIDS; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; PEROXISOMES; REACTIVE OXYGEN SPECIES;

EID: 84922394879     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2013.0446     Document Type: Review

References (97)

1. Thrash JC et al. 2011 Phylogenomic evidence for a common ancestor of mitochondria and the SAR11 clade. Sci. Rep. 1, 13. (doi:10.1038/ srep00013)
2. Yang D, Oyaizu Y, Oyaizu H, Olsen GJ, Woese CR. 1985 Mitochondrial origins. Proc. Natl Acad. Sci. USA 82, 4443-4447. (doi:10.1073/pnas.82.13.4443)
3. Yutin N, Makarova KS, Mekhedov SL, Wolf YI, Koonin EV. 2008 The deep archaeal roots of eukaryotes. Mol. Biol. Evol. 25, 1619-1630. (doi:10. 1093/molbev/msn108)
4. Huynen MA, Duarte I, Szklarczyk R. 2013 Loss, replacement and gain of proteins at the origin of the mitochondria. Biochim. Biophys. Acta 1827, 224-231. (doi:10.1016/j.bbabio.2012.08.001)
5. Lang BF, Burger G, O'Kelly CJ, Cedergren R, Golding GB, Lemieux C, Sankoff D, Turmel M, Gray MW. 1997 An ancestral mitochondrial DNA resembling a eubacterial genome in miniature. Nature 387, 493-497. (doi:10.1038/387493a0)
6. Gabaldon T, Huynen MA. 2005 Lineage-specific gene loss following mitochondrial endosymbiosis and its potential for function prediction in eukaryotes. Bioinformatics 21(Suppl. 2), ii144-ii150. (doi:10.1093/bioinformatics/bti1124)
7. Szklarczyk R, Huynen MA. 2010 Mosaic origin of the mitochondrial proteome. Proteomics 10, 4012-4024. (doi:10.1002/pmic.201000329)
8. Smeitink J, van den Heuvel L, DiMauro S. 2001 The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2, 342-352. (doi:10.1038/35072063)
9. Mitchell P. 1961 Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191, 144-148. (doi:10. 1038/191144a0)
10. Muller M et al. 2012 Biochemistry and evolution of anaerobic energy metabolism in eukaryotes. Microbiol. Mol. Biol. Rev. 76, 444-495. (doi:10. 1128/MMBR.05024-11)
11. Lane N, Martin W. 2010 The energetics of genome complexity. Nature 467, 929-934. (doi:10.1038/ nature09486)
12. Jeltsch A. 2013 Oxygen, epigenetic signaling, and the evolution of early life. Trends Biochem. Sci. 38, 172-176. (doi:10.1016/j.tibs.2013.02.001)
13. Harman D. 1981 The aging process. Proc. Natl Acad. Sci. USA 78, 7124-7128. (doi:10.1073/pnas. 78.11.7124)
14. Speijer D. 2011 Oxygen radicals shaping evolution: why fatty acid catabolism leads to peroxisomes while neurons do without it: FADH(2)/NADH flux ratios determining mitochondrial radical formation were crucial for the eukaryotic invention of peroxisomes and catabolic tissue differentiation. Bioessays 33, 88-94. (doi:10.1002/bies.201000097)
15. Turrens JF. 2003 Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335-344. (doi:10. 1113/jphysiol.2003.049478)
16. Brand MD. 2010 The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 45, 466-472. (doi:10.1016/j.exger.2010.01.003)
17. Murphy MP. 2009 How mitochondria produce reactive oxygen species. Biochem. J. 417, 1-13. (doi:10.1042/BJ20081386)
18. Andreyev AY, Kushnareva YE, Starkov AA. 2005 Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc.) 70, 200-214. (doi:10. 1007/s10541-005-0102-7)
19. Hackstein JH, Tjaden J, Huynen M. 2006 Mitochondria, hydrogenosomes and mitosomes: products of evolutionary tinkering! Curr. Genet. 50, 225-245. (doi:10.1007/s00294-006-0088-8)
20. Lindmark DG, Muller M. 1973 Hydrogenosome, a cytoplasmic organelle of the anaerobic flagellate Tritrichomonas foetus, and its role in pyruvate metabolism. J. Biol. Chem. 248, 7724-7728.
21. Danovaro R, Dell'Anno A, Pusceddu A, Gambi C, Heiner I, Kristensen RM. 2010 The first metazoa living in permanently anoxic conditions. BMC Biol. 8, 30. (doi:10.1186/1741-7007-8-30)
22. Szklarczyk R, Nooteboom M, Osiewacz HD. 2014 Control of mitochondrial integrity in ageing and disease. Phil. Trans. R. Soc. B 369, 20130439. (doi:10.1098/rstb.2013.0439)
23. Wang C, Youle RJ. 2009 The role of mitochondria in apoptosis. Annu. Rev. Genet. 43, 95-118. (doi:10. 1146/annurev-genet-102108-134850)
24. Korsmeyer SJ, Yin XM, Oltvai ZN, Veis-Novack DJ, Linette GP. 1995 Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim. Biophys. Acta 1271, 63-66. (doi:10.1016/ 0925-4439(95)00011-R)
25. Gabaldon T, Huynen MA. 2003 Reconstruction of the proto-mitochondrial metabolism. Science 301, 609. (doi:10.1126/science.1085463)
26. Gabaldon T, Huynen MA. 2004 Shaping the mitochondrial proteome. Biochim. Biophys. Acta 1659, 212-220. (doi:10.1016/j.bbabio.2004.07.011)
27. Landry CR, Townsend JP, Hartl DL, Cavalieri D. 2006 Ecological and evolutionary genomics of Saccharomyces cerevisiae. Mol. Ecol. 15, 575-591. (doi:10.1111/j.1365-294X.2006.02778.x)
28. Watmough NJ, Frerman FE. 2010 The electron transfer flavoprotein: ubiquinone oxidoreductases. Biochim. Biophys. Acta 1797, 1910-1916. (doi:10. 1016/j.bbabio.2010.10.007)
29. Brand MD et al. 2004 Mitochondrial superoxide and aging: uncoupling-protein activity and superoxide production. Biochem. Soc. Symp. 71, 203-213.
30. Iwata M, Lee Y, Yamashita T, Yagi T, Iwata S, Cameron AD, Maher MJ. 2012 The structure of the yeast NADH dehydrogenase (Ndi1) reveals overlapping binding sites for water-and lipidsoluble substrates. Proc. Natl Acad. Sci. USA 109, 15 247-15 252. (doi:10.1073/pnas.1210059109)
31. van der Zand A, Braakman I, Tabak HF. 2010 Peroxisomal membrane proteins insert into the endoplasmic reticulum. Mol. Biol. Cell 21, 2057-2065. (doi:10.1091/mbc.E10-02-0082)
32. Tabak HF, Hoepfner D, van der Zand A, Geuze HJ, Braakman I, Huynen MA. 2006 Formation of peroxisomes: present and past. Biochim. Biophys. Acta 1763, 1647-1654. (doi:10.1016/j.bbamcr. 2006.08.045)
33. Tabak HF, van der Zand A, Braakman I. 2008 Peroxisomes: minted by the ER. Curr. Opin. Cell. Biol. 20, 393-400. (doi:10.1016/j.ceb.2008.05.008)
34. van der Zand A, Gent J, Braakman I, Tabak HF. 2012 Biochemically distinct vesicles from the endoplasmic reticulum fuse to form peroxisomes. Cell 149, 397-409. (doi:10.1016/j.cell.2012.01.054)
35. Tabak HF, Braakman I, van der Zand A. 2013 Peroxisome formation and maintenance are dependent on the endoplasmic reticulum. Annu. Rev. Biochem. 82, 723-744. (doi:10.1146/annurevbiochem-081111-125123)
36. Gabaldon T, Snel B, van Zimmeren F, Hemrika W, Tabak H, Huynen MA. 2006 Origin and evolution of the peroxisomal proteome. Biol. Direct. 1, 8. (doi:10. 1186/1745-6150-1-8)
37. Reddy JK, Hashimoto T. 2001 Peroxisomal betaoxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 21, 193-230. (doi:10.1146/annurev.nutr. 21.1.193)
38. Gabaldón T. In press. A metabolic scenario for the evolutionary origin of peroxisomes from the endomembranous system. Cell. Mol. Life Sci. (doi:10. 1007/s00018-013-1424-z)
39. Speijer D. In press. Reconsidering ideas regarding the evolution of peroxisomes: the case for a mitochondrial connection. Cell. Mol. Life Sci. (doi:10. 1007/s00018-013-1507-x)
40. Schrader M, Yoon Y. 2007 Mitochondria and peroxisomes: are the 'big brother' and the 'little sister' closer than assumed? Bioessays 29, 1105-1114. (doi:10.1002/bies.20659)
41. Neuspiel M, Schauss AC, Braschi E, Zunino R, Rippstein P, Rachubinski RA, Andrade-Navarro MA, McBride HM. 2008 Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr. Biol. 18, 102-108. (doi:10. 1016/j.cub.2007.12.038)
42. Margineantu DH, Emerson CB, Diaz D, Hockenbery DM. 2007 Hsp90 inhibition decreases mitochondrial protein turnover. PLoS ONE 2, e1066. (doi:10.1371/ journal.pone.0001066)
43. Heo JM et al. 2010 A stress-responsive system for mitochondrial protein degradation. Mol. Cell 40, 465-480. (doi:10.1016/j.molcel.2010.10.021)
44. Taylor EB, Rutter J. 2011 Mitochondrial quality control by the ubiquitin-proteasome system. Biochem. Soc. Trans. 39, 1509-1513. (doi:10.1042/ BST0391509)
45. Dacks JB, Field MC. 2007 Evolution of the eukaryotic membrane-trafficking system: origin, tempo and mode. J. Cell. Sci. 120, 2977-2985. (doi:10.1242/ jcs.013250)
46. Martin W, Koonin EV. 2006 Introns and the origin of nucleus-cytosol compartmentalization. Nature 440, 41-45. (doi:10.1038/nature04531)
47. Barrientos A, Ugalde C. 2013 I function, therefore I am: overcoming skepticism about mitochondrial supercomplexes. Cell Metab. 18, 147-149. (doi:10. 1016/j.cmet.2013.07.010)
48. Lapuente-Brun E et al. 2013 Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science 340, 1567-1570. (doi:10.1126/science.1230381)
49. Moreno-Lastres D, Fontanesi F, Garcia-Consuegra I, Martin MA, Arenas J, Barrientos A, Ugalde C. 2012 Mitochondrial complex I plays an essential role in human respirasome assembly. Cell Metab. 15, 324-335. (doi:10.1016/j.cmet.2012.01.015)
50. Winge DR. 2012 Sealing the mitochondrial respirasome. Mol. Cell. Biol. 32, 2647-2652. (doi:10.1128/MCB.00573-12)
51. Gomez LA, Hagen TM. 2012 Age-related decline in mitochondrial bioenergetics: does supercomplex destabilization determine lower oxidative capacity and higher superoxide production? Semin. Cell. Dev. Biol. 23, 758-767. (doi:10.1016/j.semcdb. 2012.04.002)
52. Jastroch M, Divakaruni AS, Mookerjee S, Treberg JR, Brand MD. 2010 Mitochondrial proton and electron leaks. Essays Biochem. 47, 53-67. (doi:10.1042/ bse0470053)
53. Azzu V, Brand MD. 2010 The on-off switches of the mitochondrial uncoupling proteins. Trends Biochem. Sci. 35, 298-307. (doi:10.1016/j.tibs.2009.11.001)
54. Nicholls DG, Bernson VS, Heaton GM. 1978 The identification of the component in the inner membrane of brown adipose tissue mitochondria responsible for regulating energy dissipation. Experientia Suppl. 32, 89-93. (doi:10.1007/978-3-0348-5559-4_9)
55. Kunji ER, Robinson AJ. 2010 Coupling of proton and substrate translocation in the transport cycle of mitochondrial carriers. Curr. Opin. Struct. Biol. 20, 440-447. (doi:10.1016/j.sbi.2010.06.004)
56. Hughes J, Criscuolo F. 2008 Evolutionary history of the UCP gene family: gene duplication and selection. BMC Evol. Biol. 8, 306. (doi:10.1186/1471-2148-8-306)
57. Ricquier D, Bouillaud F. 2000 The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem. J. 345, 161-179. (doi:10.1042/ 0264-6021:3450161)
58. Esteves TC, Parker N, Brand MD. 2006 Synergy of fatty acid and reactive alkenal activation of proton conductance through uncoupling protein 1 in mitochondria. Biochem. J. 395, 619-628. (doi:10. 1042/BJ20052004)
59. Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, Pakay JL, Parker N. 2004 Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic. Biol. Med. 37, 755-767. (doi:10.1016/j.freeradbiomed. 2004.05.034)
60. Attwell D, Laughlin SB. 2001 An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow Metab. 21, 1133-1145. (doi:10.1097/ 00004647-200110000-00001)
61. Kann O, Kovacs R. 2007 Mitochondria and neuronal activity. Am. J. Physiol. Cell Physiol. 292, C641-C657. (doi:10.1152/ajpcell.00222.2006)
62. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. 2008 Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9, 505-518. (doi:10.1038/nrn2417)
63. Yang SY, He XY, Schulz H. 1987 Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme A thiolase. J. Biol. Chem. 262, 13 027-13 032.
64. Schonfeld P, Reiser G. 2013 Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J. Cereb. Blood Flow Metab. 33, 1493-1499. (doi:10.1038/ jcbfm.2013.128)
65. Schapira AH. 2012 Mitochondrial diseases. Lancet 379, 1825-1834. (doi:10.1016/S0140-6736(11) 61305-6)
66. Tucker EJ, Compton AG, Thorburn DR. 2010 Recent advances in the genetics of mitochondrial encephalopathies. Curr. Neurol. Neurosci. Rep. 10, 277-285. (doi:10.1007/s11910-010-0112-8)
67. Kirby DM, Thorburn DR. 2008 Approaches to finding the molecular basis of mitochondrial oxidative phosphorylation disorders. Twin Res. Hum. Genet. 11, 395-411. (doi:10.1375/twin.11.4.395)
68. Deuschl G, Elble R. 2009 Essential tremor: neurodegenerative or nondegenerative disease towards a working definition of ET. Mov. Disord. 24, 2033-2041. (doi:10.1002/mds.22755)
69. Przedborski S, Vila M, Jackson-Lewis V. 2003 Neurodegeneration: what is it and where are we? J. Clin. Invest. 111, 3-10. (doi:10.1172/JCI17522)
70. Breuer ME, Koopman WJ, Koene S, Nooteboom M, Rodenburg RJ, Willems PH, Smeitink JA. 2013 The role of mitochondrial OXPHOS dysfunction in the development of neurologic diseases. Neurobiol. Dis. 51, 27-34. (doi:10.1016/j.nbd.2012.03.007)
71. Koopman WJ, Distelmaier F, Smeitink JA, Willems PH. 2013 OXPHOS mutations and neurodegeneration. EMBO J. 32, 9-29. (doi:10. 1038/emboj.2012.300)
72. Fukui H, Moraes CT. 2008 The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci. 31, 251-256. (doi:10.1016/j.tins. 2008.02.008)
73. DiFilippo M, Chiasserini D, Tozzi A, Picconi B, Calabresi P. 2010 Mitochondria and the link between neuroinflammation and neurodegeneration. J. Alzheimers Dis. 20(Suppl. 2), S369-S379. (doi:10.3233/JAD-2010-100543)
74. Dutta R et al. 2006 Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann. Neurol. 59, 478-489. (doi:10.1002/ ana.20736)
75. Lin MT, Beal MF. 2006 Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. (doi:10.1038/nature05292)
76. Scaglia F. 2010 The role of mitochondrial dysfunction in psychiatric disease. Dev. Disabil. Res. Rev. 16, 136-143. (doi:10.1002/ddrr.115)
77. de Moura MB, dos Santos LS, Van Houten B. 2010 Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ. Mol. Mutagen. 51, 391-405. (doi:10.1002/em.20575)
78. Tansey MG, Goldberg MS. 2010 Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 37, 510-518. (doi:10.1016/ j.nbd.2009.11.004)
79. Mortiboys H et al. 2008 Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann. Neurol. 64, 555-565. (doi:10. 1002/ana.21492)
80. Heeman B et al. 2011 Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. J. Cell. Sci. 124, 1115-1125. (doi:10.1242/jcs.078303)
81. Mounsey RB, Teismann P. 2010 Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection. Parkinsons Dis. 2011, 617472. (doi:10.4061/2011/617472)
82. Winkler-Stuck K, Wiedemann FR, Wallesch CW, Kunz WS. 2004 Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients. J. Neurol. Sci. 220, 41-48. (doi:10.1016/j.jns.2004.02.003)
83. Vos M et al. 2012 Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science 336, 1306-1310. (doi:10.1126/science.1218632)
84. Goodall EF, Morrison KE. 2006 Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev. Mol. Med. 8, 1-22. (doi:10.1017/S146239940 6010854)
85. Israelson A, Arbel N, Da CS, Ilieva H, Yamanaka K, Shoshan-Barmatz V, Cleveland DW. 2010 Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 67, 575-587. (doi:10.1016/j.neuron.2010.07.019)
86. Perry RJ, Hodges JR. 1999 Attention and executive deficits in Alzheimer's disease. A critical review. Brain 122, 383-404. (doi:10.1093/brain/122. 3.383)
87. Kar S, Slowikowski SP, Westaway D, Mount HT. 2004 Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J. Psychiatry Neurosci. 29, 427-441.
88. Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC. 2010 Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J. Alzheimers Dis. 20(Suppl. 2) S535-S550. (doi:10.3233/JAD-2010-100342)
89. Reddy PH, Beal MF. 2008 Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 14, 45-53. (doi:10.1016/j.molmed.2007.12.002)
90. Morais VA, De Strooper B. 2010 Mitochondria dysfunction and neurodegenerative disorders: cause or consequence. J. Alzheimers Dis. 20(Suppl. 2), S255-S263. (doi:10.3233/JAD-2010-100345)
91. Balsa E, Marco R, Perales-Clemente E, Szklarczyk R, Calvo E, Landazuri MO, Enriquez JA. 2012 NDUFA4 is a subunit of complex IV of the mammalian electron transport chain. Cell Metab. 16, 378-386. (doi:10. 1016/j.cmet.2012.07.015)
92. Gabaldon T, Rainey D, Huynen MA. 2005 Tracing the evolution of a large protein complex in the eukaryotes, NADH:ubiquinone oxidoreductase (complex I). J. Mol. Biol. 348, 857-870. (doi:10. 1016/j.jmb.2005.02.067)
93. Cardol P. 2011 Mitochondrial NADH:ubiquinone oxidoreductase (complex I) in eukaryotes: a highly conserved subunit composition highlighted by mining of protein databases. Biochim. Biophys. Acta 1807, 1390-1397. (doi:10.1016/j.bbabio. 2011.06.015)
94. Huynen MA, de Hollander M, Szklarczyk R. 2009 Mitochondrial proteome evolution and genetic disease. Biochim. Biophys. Acta 1792, 1122-1129. (doi:10.1016/j.bbadis.2009.03.005)
95. Nouws J et al. 2010 Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I. Cell Metab. 12, 283-294. (doi:10.1016/j.cmet.2010.08.002)
96. Hamalainen RH, Manninen T, Koivumaki H, Kislin M, Otonkoski T, Suomalainen A. 2013 Tissue-and celltype-specific manifestations of heteroplasmic mtDNA 3243A. G mutation in human induced pluripotent stem cell-derived disease model. Proc. Natl Acad. Sci. USA 110, E3622-E3630. (doi:10. 1073/pnas.1311660110)
97. Gurusamy N, Das DK. 2009 Autophagy, redox signaling, and ventricular remodeling. Antioxid. Redox Signal. 11, 1975-1988. (doi:10.1089/ARS. 2009.2524)